TIMP3 and cancer: Considering the impact of the shift in the balance of shed versus unshed BG (modified and unmodified), it is worth noting that TIMP3, that we defined here as a regulator BG ectodomain shedding, is also altered in several cancers and has been proposed as a therapeutic target [90].